Medtronic (WBO:MDT) Debt-to-Asset : 0.32 (As of Oct. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Medtronic Debt-to-Asset?

Medtronic's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Oct. 2024 was €3,414 Mil. Medtronic's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Oct. 2024 was €22,589 Mil. Medtronic's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Oct. 2024 was €82,659 Mil. Medtronic's debt to asset for the quarter that ended in Oct. 2024 was 0.31.

Medtronic Debt-to-Asset Historical Data

The historical data trend for Medtronic's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medtronic Debt-to-Asset Chart

Medtronic Annual Data

Trend

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Apr24

Debt-to-Asset

Get a 7-Day Free Trial

0.27

0.28

0.27

0.28

Medtronic Quarterly Data
	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24
Debt-to-Asset	Get a 7-Day Free Trial															0.28	0.28	0.28	0.31	0.32

Competitive Comparison of Medtronic's Debt-to-Asset

For the Medical Devices subindustry, Medtronic's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medtronic's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medtronic's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Medtronic's Debt-to-Asset falls into.

Medtronic Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Medtronic's Debt-to-Asset for the fiscal year that ended in Apr. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(1017.744	+	22304.624)	/	83862.292
	=	0.28

Medtronic's Debt-to-Asset for the quarter that ended in Oct. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(3414.042	+	22589.226)	/	82658.556
	=	0.31

Medtronic (WBO:MDT) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Medtronic Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Medtronic's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Medtronic Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medtronic PLC (WBO:MDT) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

MDT:USA MDTN:Mexico 1MDT:Italy 0Y6X:UK 2M6:Germany 2M6:Germany 2M6:Germany 2M6:Germany MDTC34:Brazil MDT:Argentina

Address

Lower Hatch Street, 20 On Hatch, Dublin, IRL, 2

Website

https://www.medtronic.com

One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for roughly 50% of the company's total sales.